Work

CD34+ -selected hematopoietic stem cell transplant conditioned with a myeloablative regimen in patients with advanced myelofibrosis

Year: 2022

Type: article

Study design: Observational Study

Source: Bone Marrow Transplantation

DOI: 10.1038/s41409-022-01684-9

Authors: Mariam T. Nawas, Jeong-Ok Lee, Jessica Flynn, Molly Maloy, Ann A. Jakubowski, Esperanza B. Papadopoulos, Christina Cho, Doris M. Ponce, Craig S. Sauter, Miguel-Angel Perales, Sean Devlin, Sergio A. Giralt, Hugo R. Castro-Malaspina, Roni Tamari

Institutions: University of Chicago, University of Chicago Medical Center, Seoul National University, Seoul National University Bundang Hospital, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: Immunobiology of Allogeneic Hematopoietic Cell Transplantation, Cancer Center Support Grant

OpenAlex ID: W4224989471

FWCI: 0.776

Cites: 34

Cited by: 5

Related to: 10